secwatch.observer — SEC 8-K summary
======================================

Issuer:     QUEST DIAGNOSTICS INC (DGX)
CIK:        0001022079
Form:       8-K
Filed at:   2022-05-20T23:59:59+00:00
Accession:  0000947871-22-000627
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quest Diagnostics amends charter to allow written consent, lower special meeting threshold to 15%
--------------------------------------------------------------------------------

- Stockholders approved written consent actions with minimum votes needed, replacing prior unanimous consent requirement.
- Ownership threshold to request special meeting reduced from 20% to 15% of outstanding shares.
- Amendment to Restated Certificate of Incorporation filed effective May 19, 2022.
- Board amended and restated By-Laws to align with new consent and meeting procedures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1022079/000094787122000627/0000947871-22-000627-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1022079/000094787122000627/ss1016027_8k.htm
  HTML page:      https://secwatch.observer/filing/0000947871-22-000627

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer